Glaxosmithkline Pharmaceuticals Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Glaxosmithkline Pharmaceuticals Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

Glaxosmithkline Pharmaceuticals Ltd.

BSE: 500660, NSE: GLAXO

  • Market Capitalisation info

    ₹25,048 Cr


  • 12 Month Earnings info

    ₹1,693 Cr

  • Price to Earnings info

    14.77

₹1,478.55

As on 18-Aug-2022 IST

up-down-arrow16.701.14%

  • Prev Close info

    1,461.85

  • Day's Openinfo

    1,461.00

  • Today's Highinfo

    1,487.00

  • Today's Lowinfo

    1,457.65

  • Today's Volumeinfo

    63,406

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Glaxosmithkline Pharma
-15.83 -2.07 -2.77 -7.24 6.81 4.33 3.54
S&P BSE Healthcare
-11.36 2.81 2.55 -11.43 23.02 12.05 12.21
S&P BSE Mid Cap
1.27 10.64 11.39 9.65 23.30 10.67 15.17
As on 18-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Glaxosmithkline Pharma
9.01 -0.48 7.50 23.05 -8.81 -17.15 4.55
S&P BSE Mid Cap
39.18 19.87 -3.05 -13.31 48.13 7.97 7.43
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88 15.06

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        Other Details

        Incorporated

        1924

        Chairman

        R S Karnad

        Managing Director

        S Venkatesh

        Group

        Glaxosmithkline - MNC

        Headquarters

        Mumbai, Maharashtra
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹25,048.38 Cr

        • Revenue (TTM) info

          ₹3,380.52 Cr

        • Earnings (TTM) info

          ₹1,692.92 Cr

        • Cash info

          ₹2,850.10 Cr

        • Total Debt info

          ₹0.00 Cr

        • Promoters' ownership info

          75.00%

        • Liquidity info

          High

        • 52 Week range info

          ₹1,372.05 - 1,918.75

        • Face value info

          ₹10.00

        • Shares outstanding info

          16,94,06,034

        • 10 Years Aggregate:

          CFO: ₹4,067.26 Cr

          EBITDA: ₹5,855.76 Cr

          Net Profit: ₹3,790.27 Cr

        About The Company

        • Business

          Manufacture of allopathic pharmaceutical preparations

        • Incorporated

          1924

        • Chairman

          R S Karnad

        • Managing Director

          S Venkatesh

        • Group

          Glaxosmithkline - MNC

        • Listing info

          BSE: 500660, NSE: GLAXO

        • Country

          India

        • Headquarters info

          Mumbai, Maharashtra

        • Website info

          www.gsk-india.com